ArticleBMC pharmacology & toxicology2026

Computational-experimental repurposing reveals synergistic sorafenib/hydroxychloroquine response in KRAS-mutant breast cancer.

Mohammad M Abdelwahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.